145 related articles for article (PubMed ID: 8509222)
1. Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN alpha/beta therapy of Friend erythroleukemia visceral metastases.
Kaido T; Gresser I; Maury C; Maunoury MT; Vignaux F; Belardelli F
Int J Cancer; 1993 May; 54(3):475-81. PubMed ID: 8509222
[TBL] [Abstract][Full Text] [Related]
2. The essential role of endogenous IFN alpha/beta in the anti-metastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells.
Gresser I; Maury C; Kaido T; Bandu MT; Tovey MG; Maunoury MT; Fantuzzi L; Gessani S; Greco G; Belardelli F
Int J Cancer; 1995 Nov; 63(5):726-31. PubMed ID: 7591292
[TBL] [Abstract][Full Text] [Related]
3. Interaction of IFN alpha/beta with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice.
Gresser I; Kaido T; Maury C; Woodrow D; Moss J; Belardelli F
Int J Cancer; 1994 May; 57(4):604-11. PubMed ID: 8181864
[TBL] [Abstract][Full Text] [Related]
4. Successful immunotherapy of the highly metastatic murine ESb lymphoma with sensitized CD8+ T cells and IFN-alpha/beta.
Kaido T; Maury C; Schirrmacher V; Gresser I
Int J Cancer; 1994 May; 57(4):538-43. PubMed ID: 8181857
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Friend leukemia cell visceral metastases by a new monoclonal antibody and role of the immune system of the host in its action.
Sala A; Gresser I; Chassoux D; Maury C; Santodonato L; Eid P; Maunoury MT; Barca S; Cianfriglia M; Belardelli F
Cancer Res; 1992 May; 52(10):2880-9. PubMed ID: 1581903
[TBL] [Abstract][Full Text] [Related]
6. Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon alpha/beta treatment in mice.
Gresser I; Carnaud C; Maury C; Sala A; Eid P; Woodrow D; Maunoury MT; Belardelli F
J Exp Med; 1991 May; 173(5):1193-203. PubMed ID: 2022926
[TBL] [Abstract][Full Text] [Related]
7. Host CD4+ T lymphocytes are required for the synergistic action of interferon-alpha/beta and adoptively transferred immune cells in the inhibition of visceral ESb metastases.
Kaido TJ; Maury C; Gresser I
Cancer Res; 1995 Dec; 55(24):6133-9. PubMed ID: 8521404
[TBL] [Abstract][Full Text] [Related]
8. Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.
Gabriele L; Kaido T; Woodrow D; Moss J; Ferrantini M; Proletti E; Santodonato L; Rozera C; Maury C; Belardelli F
Am J Pathol; 1995 Aug; 147(2):445-60. PubMed ID: 7639337
[TBL] [Abstract][Full Text] [Related]
9. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
[TBL] [Abstract][Full Text] [Related]
10. Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice.
Gresser I; Maury C; Vignaux F; Haller O; Belardelli F; Tovey MG
J Exp Med; 1988 Oct; 168(4):1271-91. PubMed ID: 3171480
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases.
Gresser I; Maury C; Carnaud C; De Maeyer E; Maunoury MT; Belardelli F
Int J Cancer; 1990 Sep; 46(3):468-74. PubMed ID: 2394514
[TBL] [Abstract][Full Text] [Related]
12. Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastases.
Ciolli V; Gabriele L; Sestili P; Varano F; Proietti E; Gresser I; Testa U; Montesoro E; Bulgarini D; Mariani G
J Exp Med; 1991 Feb; 173(2):313-22. PubMed ID: 1671080
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.
Yasui H; Proietti E; Vignaux F; Eid P; Gresser I
Cancer Res; 1990 Jun; 50(12):3533-9. PubMed ID: 2140290
[TBL] [Abstract][Full Text] [Related]
14. Importance of interferon alpha in the resistance of allogeneic C57B1/6 mice to the multiplication of Friend erythroleukemia cells in the liver.
Gresser I; Maury C; Bandu MT; Belardelli F
Int J Cancer; 1990 Feb; 45(2):364-71. PubMed ID: 2406205
[TBL] [Abstract][Full Text] [Related]
15. Synergistic anti-tumor effects of combined IL-1/IFN-alpha/beta therapy in mice injected with metastatic Friend erythroleukemia cells.
Belardelli F; Gabriele L; Proietti E; Sestili P; Peretti M; Rozera C; Gresser I
Int J Cancer; 1991 Sep; 49(2):274-8. PubMed ID: 1879971
[TBL] [Abstract][Full Text] [Related]
16. Intranasal administration of IFN-alpha/beta inhibits the development of visceral tumor metastases.
Kaido TJ
J Interferon Cytokine Res; 1997 Jan; 17(1):31-6. PubMed ID: 9041469
[TBL] [Abstract][Full Text] [Related]
17. Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir.
Santodonato L; Ferrantini M; Gabriele L; Proietti E; Venditti M; Musiani P; Modesti A; Modica A; Lupton SD; Belardelli F
Hum Gene Ther; 1996 Jan; 7(1):1-10. PubMed ID: 8825863
[TBL] [Abstract][Full Text] [Related]
18. Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells.
Gresser I; Maury C; Woodrow D; Moss J; Grütter MG; Vignaux F; Belardelli F; Maunoury MT
Int J Cancer; 1988 Jan; 41(1):135-42. PubMed ID: 3422071
[TBL] [Abstract][Full Text] [Related]
19. A radiosensitive T-lymphocyte associated with resistance of DBA/2 mice harboring Friend leukemia virus-dormant infections to transplantable Friend leukemia virus-erythroleukemia cells.
DiCicco LM; Truitt GA; Wheelock EF
Cancer Res; 1986 Jan; 46(1):127-32. PubMed ID: 3509990
[TBL] [Abstract][Full Text] [Related]
20. Studies on the expression of H-2 antigens in non-metastatic and highly metastatic Friend erythroleukemia cells: correlation with the in vivo behaviour of tumor cells.
Ferrantini M; Pulciani S; Proietti E; Lespinats G; Anastasi A; Ciolli V; Rizza P; Belardelli F
Clin Exp Metastasis; 1989; 7(6):609-25. PubMed ID: 2476272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
